Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

After multiple short-term extensions, telehealth providers are eager for Congress to lay out its long-term plans for the ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance industry. Much of the outcry has centered not on the killing itself ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

One of those experts was Stanley Biber, a pioneer of vaginoplasties in the U.S. and perhaps the country’s busiest ...

It is time for us to dispel the darkness of our health care industry through the light of integrity and compassion,” writes ...

Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...